Alterity Therapeutics (ATHE) Total Current Liabilities (2009 - 2025)

Alterity Therapeutics' Total Current Liabilities history runs 16 years deep, the most recent figure standing at $1.7 million for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 4.49% year-over-year to $1.7 million; the TTM figure through Dec 2025 stood at $1.7 million (down 4.49% YoY), while the FY2025 annual figure was $2.3 million, up 144.37% from the prior year.
• Total Current Liabilities was $1.7 million for Q4 2025 at Alterity Therapeutics, down from $2.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $4.2 million in Q2 2022 to a low of $1.7 million in Q4 2025.
• Historically, Total Current Liabilities has averaged $2.8 million across 5 years, with a median of $2.8 million in 2021.
• The sharpest annual moves came in 2022 and 2024: Total Current Liabilities surged 76.48% in 2022, then plunged 39.23% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $2.7 million in 2021, then grew by 25.41% to $3.4 million in 2022, then slipped by 14.91% to $2.9 million in 2023, then slumped by 39.23% to $1.8 million in 2024, then fell by 4.49% to $1.7 million in 2025.
• The last three Total Current Liabilities figures came in at $1.7 million (Q4 2025), $2.3 million (Q2 2025), and $1.8 million (Q4 2024), per Business Quant data.